FDA NDC Directory · JSON-LD · Markdown

Elzonris

NDC 72187-0401 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametagraxofusp
Labeler / ManufacturerStemline Therapeutics, Inc.
Marketing categoryBiologic License Application · App BLA761116
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsTAGRAXOFUSP (1000 ug/mL)
Marketing started20190118
Package count1

External sources

Source: openFDA. Public-domain (CC0).